These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32947304)

  • 1. Prognostic and Predictive Factors in Metastatic Renal Cell Carcinoma: Current Perspective and a Look Into the Future.
    Gan CL; Dudani S; Heng DYC
    Cancer J; 2020; 26(5):365-375. PubMed ID: 32947304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in renal cell carcinoma.
    Shuch BM; Lam JS; Belldegrun AS; Figlin RA
    Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized Management of Advanced Kidney Cancer.
    Graham J; Heng DYC; Brugarolas J; Vaishampayan U
    Am Soc Clin Oncol Educ Book; 2018 May; 38():330-341. PubMed ID: 30231375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genomics of renal cell carcinoma and its role in renal mass biopsy.
    Salami SS; George AK; Udager AM
    Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
    de Velasco G; Culhane AC; Fay AP; Hakimi AA; Voss MH; Tannir NM; Tamboli P; Appleman LJ; Bellmunt J; Kimryn Rathmell W; Albiges L; Hsieh JJ; Heng DY; Signoretti S; Choueiri TK
    Oncologist; 2017 Mar; 22(3):286-292. PubMed ID: 28220024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.
    Arsanious A; Bjarnason GA; Yousef GM
    Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.
    Bex A; Gore M; Mulders P; Sternberg CN
    BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications.
    Li M; Wang Y; Cheng L; Niu W; Zhao G; Raju JK; Huo J; Wu B; Yin B; Song Y; Bu R
    Oncotarget; 2017 Jul; 8(29):48424-48435. PubMed ID: 28467794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics.
    Takahashi M; Sugimura J; Yang X; Vogelzang N; Teh BS; Furge K; Teh BT
    Adv Cancer Res; 2003; 89():157-81. PubMed ID: 14587873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting outcome in renal cell carcinoma.
    Sun M; Shariat SF; Karakiewicz PI
    Curr Opin Urol; 2010 Sep; 20(5):355-60. PubMed ID: 20592610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and prognostic models for renal cell carcinoma: a literature review.
    Klatte T; Rossi SH; Stewart GD
    World J Urol; 2018 Dec; 36(12):1943-1952. PubMed ID: 29713755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics of renal cell cancer: the biology behind and the therapy ahead.
    Jones J; Libermann TA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):685s-692s. PubMed ID: 17255294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications.
    Hahn AW; Gill DM; Maughan B; Agarwal A; Arjyal L; Gupta S; Streeter J; Bailey E; Pal SK; Agarwal N
    Oncotarget; 2017 May; 8(20):33614-33620. PubMed ID: 28431395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
    Lam JS; Leppert JT; Figlin RA; Belldegrun AS
    Urology; 2005 Nov; 66(5 Suppl):1-9. PubMed ID: 16194700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy.
    Al-Ali BM; Ress AL; Gerger A; Pichler M
    Anticancer Res; 2012 Sep; 32(9):3727-32. PubMed ID: 22993312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.